News Focus
News Focus
icon url

richme

01/27/16 6:14 PM

#180972 RE: no2koolaid #180961

For me there is no issue of confusion but of trust. CEO issued an invitation to the board to doubt his word with schedule promises or if one prefers quasi-promises. CEO word is not his bond because he always has the "forward looking statement" which holds he can say nearly anything and will never be called on the carpet. However, refusing to divulge the valuation company has nothing to do with protecting the company from competitors, it was pure and simple protecting a falsehood and without verification or as would be said "links" there is no way to tell if he was telling the truth. I don't believe he was.
icon url

John_Langston

01/27/16 7:19 PM

#180989 RE: no2koolaid #180961

Perhaps the confusion is over the word - immediately




There is no confusion over the word “immediately” for savvy OTC investors; we are use to the nasRAT BS.
icon url

dr_lowenstein

01/27/16 8:51 PM

#181026 RE: no2koolaid #180961

actually what he said was:FDA notification regarding acceptance of the submission for review is expected to take 6 to 12 weeks.

If I am not mistaken, 6 weeks is 1.5 MONTHS, and 12 weeks is 3 MONTHS, therefore it is incorrect to say that it might not be MONTHS,
PERIOD LOL LOL